The Performance of Cerebrospinal Fluid Treponemal-Specific Antibody Tests in Neurosyphilis
- 1 April 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Sexually Transmitted Diseases
- Vol. 39 (4), 291-297
- https://doi.org/10.1097/olq.0b013e31824c0e62
Abstract
No single laboratory test is both sensitive and specific to diagnose neurosyphilis. Several major clinical guidelines suggest that negative cerebrospinal fluid (CSF) treponemal-specific antibody tests rule out the diagnosis of neurosyphilis. Our aim was to systematically review the literature and describe the performance of treponemal-specific CSF antibody tests when diagnosing neurosyphilis. Two reviewers independently assessed studies published in electronic databases, trial registries, and bibliographies for content and quality. Entry criteria included the assessment of treponemal-specific CSF tests currently used in clinical practice, and the use of standard criteria for both diagnosis and exclusion of neurosyphilis. The primary outcomes were sensitivity, specificity, and negative predictive values of treponemal-specific CSF antibody tests. Of 141 unique citations, 18 studies were included in the systematic review. Due to significant heterogeneity among studies, we were unable to generate pooled summary statistics. Seven different treponemal-specific tests were assessed. Of those, 13 studies evaluated the CSF FTA-ABS (fluorescent treponemal antibody-absorbed) and 9 evaluated the CSF fluorescent treponemal antibody. The performance estimates of these tests were highly variable and depended on the choice of negative and positive controls. No single test had perfect sensitivity, thus the negative predictive value was dependant on the specificity of the test and the prevalence (i.e., pretest probability) of neurosyphilis: the higher the prevalence, the lower the negative predictive value. Few studies included HIV-infected persons. A negative CSF-treponemal-specific antibody test may not exclude the diagnosis of neurosyphilis when the clinical suspicion for neurosyphilis is high.Keywords
This publication has 24 references indexed in Scilit:
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Cerebrospinal Fluid Treponemal Antibodies in Untreated Early SyphilisArchives of Neurology, 1995
- Diagnosis of Neurosyphilis: A Critical Assessment of Current MethodsSouthern Medical Journal, 1988
- Diagnostic DecisionAnnals of Internal Medicine, 1986
- Diagnosis of neurosyphilis by examination of the cerebrospinal fluid.Sexually Transmitted Infections, 1981
- Further evaluation of the microhaemagglutination test to determine treponemal antibodies in CSF.Sexually Transmitted Infections, 1980
- Evaluation of microhaemagglutination assay to determine treponemal antibodies in CSF.Sexually Transmitted Infections, 1979
- Utility of the FTA-Abs Test of Cerebrospinal Fluid in the Diagnosis of NeurosyphilisSexually Transmitted Diseases, 1979
- Fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test. A provisional technique.Sexually Transmitted Infections, 1972
- NeurosyphilisJAMA, 1972